Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$798M |
| 2 |
AT&T
T
|
+$527M |
| 3 |
Microchip Technology
MCHP
|
+$472M |
| 4 |
Netflix
NFLX
|
+$446M |
| 5 |
PNC Financial Services
PNC
|
+$444M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$694M |
| 2 |
KeyCorp
KEY
|
+$401M |
| 3 |
Deere & Co
DE
|
+$322M |
| 4 |
CSX Corp
CSX
|
+$318M |
| 5 |
NXP Semiconductors
NXPI
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.93% |
| 2 | Technology | 4.66% |
| 3 | Healthcare | 4.45% |
| 4 | Industrials | 4.14% |
| 5 | Consumer Discretionary | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIT
3926
PUT
DELISTED
CIT Group Inc.
CIT
| $2.42M | ﹤0.01% |
46,900
-26,400
| -36% | -$1.41M |
|
|
MZTI
3927
The Marzetti Company
MZTI
$3.18B
| $2.42M | ﹤0.01% |
16,219
+5,650
| +53% | +$842K |
|
3928
Hartford Multifactor Emerging Markets ETF
ROAM
$112M
| $2.42M | ﹤0.01% |
104,586
-31,612
| -23% | -$726K |
|
3929
B2Gold
BTG
$6.79B
| $2.42M | ﹤0.01% |
1,057,567
-600,236
| -36% | -$1.42M |
|
3930
Invesco S&P SmallCap Consumer Staples ETF
PSCC
$42M
| $2.42M | ﹤0.01% |
+87,105
| New | +$2.43M |
|
3931
CALL
Copart
CPRT
$29.3B
| $2.41M | ﹤0.01% |
187,200
+13,200
| +8% | +$197K |
|
3932
WisdomTree Trust WisdomTree China ex-State-Owned Enterprises Fund
CXSE
$495M
| $2.41M | ﹤0.01% |
67,284
+18,384
| +38% | +$693K |
|
3933
CALL
Adient
ADNT
$1.57B
| $2.41M | ﹤0.01% |
61,300
+10,000
| +19% | +$451K |
|
3934
Intrepid Potash
IPI
$493M
| $2.41M | ﹤0.01% |
67,123
+6,617
| +11% | +$242K |
|
3935
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.33B
| $2.41M | ﹤0.01% |
79,040
-68,315
| -46% | -$2.04M |
|
3936
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
| $2.41M | ﹤0.01% |
+72,012
| New | +$2.36M |
|
|
RP
3937
CALL
DELISTED
RealPage, Inc.
RP
| $2.4M | ﹤0.01% |
36,500
+24,700
| +209% | +$1.47M |
|
3938
Modine Manufacturing
MOD
$11.1B
| $2.4M | ﹤0.01% |
161,340
-6,610
| -4% | -$112K |
|
3939
ProShares UltraPro Dow 30
UDOW
$924M
| $2.4M | ﹤0.01% |
88,096
-16,200
| -16% | -$402K |
|
|
XLRN
3940
PUT
DELISTED
Acceleron Pharma
XLRN
| $2.4M | ﹤0.01% |
42,000
-34,200
| -45% | -$1.68M |
|
3941
CALL
Peabody Energy
BTU
$3.11B
| $2.4M | ﹤0.01% |
67,400
+53,800
| +396% | +$2.31M |
|
3942
Steven Madden
SHOO
$3.45B
| $2.4M | ﹤0.01% |
+68,006
| New | +$2.52M |
|
3943
Independent Bank
INDB
$4.07B
| $2.4M | ﹤0.01% |
29,012
+12,236
| +73% | +$1.07M |
|
3944
ePlus
PLUS
$2.31B
| $2.4M | ﹤0.01% |
51,708
+9,392
| +22% | +$469K |
|
3945
CALL
CRISPR Therapeutics
CRSP
$5.18B
| $2.4M | ﹤0.01% |
54,000
-26,400
| -33% | -$1.38M |
|
3946
CALL
Waters Corp
WAT
$40.5B
| $2.4M | ﹤0.01% |
12,300
+600
| +5% | +$116K |
|
3947
PUT
Littelfuse
LFUS
$11.6B
| $2.39M | ﹤0.01% |
12,100
+8,900
| +278% | +$1.96M |
|
3948
CALL
Essex Property Trust
ESS
$18.5B
| $2.39M | ﹤0.01% |
9,700
+6,900
| +246% | +$1.66M |
|
3949
Illinois Tool Works
ITW
$82.8B
| $2.39M | ﹤0.01% |
16,959
-73,990
| -81% | -$10.4M |
|
|
DCP
3950
CALL
DELISTED
DCP Midstream, LP
DCP
| $2.39M | ﹤0.01% |
60,400
+31,100
| +106% | +$1.31M |
|
Similar funds
Ken Griffin's Q3 2018 Portfolio in Review
As of Q3 2018, Ken Griffin held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ken Griffin deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.
By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.
- Ken Griffin's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
- Ken Griffin added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
- Ken Griffin's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
- Ken Griffin fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
- Ken Griffin's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
- Ken Griffin opened 1,427 new positions and closed 1,043 in Q3 2018.
- Ken Griffin's portfolio value rose 10% quarter-over-quarter to $224B.
Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.